Catalent
CTLT
#1601
Rank
$10.78 B
Marketcap
$59.41
Share price
-0.85%
Change (1 day)
77.08%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - P/B ratio

P/B ratio as of November 2024 : 2.99

According to Catalent's latest financial reports the company has a price-to-book ratio of 2.46145.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Catalent - P/B ratio (from 2014 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-312.2033.49%
2022-12-311.65-67.76%
2021-12-315.1113.82%
2020-12-314.4926.62%
2019-12-313.5522.15%
2018-12-312.91-46.48%
2017-12-315.43-5.1%
2016-12-315.7211.47%
2015-12-315.13-26.8%
2014-12-317.01
2013-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.11-29.45%๐Ÿ‡บ๐Ÿ‡ธ USA
1.99-33.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
11.1 269.68%๐Ÿ‡บ๐Ÿ‡ธ USA